CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 27 enrolled
Drug / intervention
3M CHG/IPA Surgical Skin Preparation - Abdominal Region +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02447497
NCT02447497Phase 2Completed
CompareCT.gov

Assessment of Antimicrobial Persistence of 3M CHG/IPA Preoperative Skin Preparation Against Resident Flora on the Abdominal and Inguinal Regions

Solventum US LLC·interventional·Posted May 19, 2015·Updated Oct 2, 2024

In Brief

A Phase 2 clinical trial evaluating 3M CHG/IPA Surgical Skin Preparation - Abdominal Region, Normal Saline - Abdominal Region, and 2 other interventions for Bacterial Recovery of Skin Flora Post-Product Application. Completed, enrolled 27 participants across 1 site.

Detailed Summary

The objective of the study is to demonstrate persistence of the CHG/IPA Prep on skin flora of the abdominal and inguinal regions of human subjects.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBacterial Recovery of Skin Flora Post-Product Application
CountriesUnited States
Collaborators3M

Timeline

Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
First PostedMay 19, 2015
Enrollment StartMar 1, 2015
Primary CompletionApr 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 11.1 years ago

Interventions

3M CHG/IPA Surgical Skin Preparation - Abdominal Regiondrug

Chlorhexidine gluconate 2% / Isopropyl alcohol 70%

Normal Saline - Abdominal Regionother

0.9% sodium chloride applied with foam applicator

3M CHG/IPA Surgical Skin Preparation - Inguinal Regiondrug

Chlorhexidine gluconate 2% / Isopropyl alcohol 70%

Normal Saline - Inguinal Regionother

0.9% sodium chloride applied with foam applicator